{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:07:54Z","timestamp":1791151674480,"version":"4.1.0"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2003,12,30]],"date-time":"2003-12-30T00:00:00Z","timestamp":1072742400000},"content-version":"vor","delay-in-days":424,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>In the United States, an estimated 200,000 persons are infected with both hepatitis C virus (HCV) and human immunodeficiency virus (HIV). As the lives of HIV-infected persons have been prolonged by use of highly active antiretroviral therapy, liver disease has emerged as an important, and in some settings, the leading cause of morbidity and mortality. Human immunodeficiency virus infection appears to adversely affect all stages of hepatitis C infection, leading to increased viral persistence and accelerated progression of HCV-related liver disease. In turn, hepatitis C may affect the management of HIV infection, increasing the incidence of liver toxicity caused by antiretroviral medications. The medical management of hepatitis C in HIV-infected persons remains controversial, in part because of the complexity of both infections and potential drug interactions, but chiefly because there is so little published information. Nonetheless, the burden of liver disease is too high to delay management of HIV\/HCV-coinfected persons while awaiting better data. Instead, the management of hepatitis C today must be based on data generated on persons without HIV and an understanding of both infections. Properly designed studies of therapy in HIV\/HCV-coinfected persons are needed to help guide management of these patients in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1053\/jhep.2002.36380","type":"journal-article","created":{"date-parts":[[2002,10,31]],"date-time":"2002-10-31T22:50:56Z","timestamp":1036104656000},"page":"s201-s209","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":34,"title":["Hepatitis C and human immunodeficiency virus infection"],"prefix":"10.1097","volume":"36","author":[{"given":"David L.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1053\/jhep.2002.36380-BIB1|cit1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/339042","article-title":"Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group","volume":"34","author":"Sherman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB2|cit2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/jhep.2002.36380-BIB3|cit3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB4|cit4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/321819","article-title":"Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection","volume":"33","author":"Monga","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB5|cit5","first-page":"1","article-title":"Updated U.S. Public Health Service guidelines on the management of occupational exposures to HBV, HCV, and HIV and recommendations for post-exposure prophylaxis","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/jhep.2002.36380-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/JCM.35.12.3274-3277.1997","article-title":"Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland","volume":"35","author":"Villano","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1053\/jhep.2002.36380-BIB7|cit7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM198707233170411","article-title":"Transfusion-associated hepatitis and AIDS","volume":"317","author":"Bove","year":"1987","journal-title":"What is the risk? N Engl J Med"},{"key":"10.1053\/jhep.2002.36380-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(97)05413-5","article-title":"Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C","volume":"350","author":"Darby","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","article-title":"The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study","volume":"334","author":"Schreiber","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/jhep.2002.36380-BIB10|cit10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(87)91725-9","article-title":"Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study","volume":"1","author":"Kingsley","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199606203342501","article-title":"Obstetrical factors and the transmission of human immunodeficiency virus type I from mother to child","volume":"334","author":"Landesman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/jhep.2002.36380-BIB12|cit12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(95)90277-5","article-title":"Mother-to-infant transmission of hepatitis C virus","volume":"345","author":"Zanetti","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/515315","article-title":"Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers","volume":"177","author":"Thomas","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB14|cit14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/infdis\/171.4.768","article-title":"Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 sex partnerships","volume":"171","author":"Thomas","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB15|cit15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-115-10-764","article-title":"Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV)","volume":"115","author":"Eyster","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/jhep.2002.36380-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(00)04331-2","article-title":"Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda","volume":"357","author":"Gray","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB17|cit17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0163-4453(94)91128-2","article-title":"Hepatitis C virus infection in sexually active homosexual men","volume":"29","author":"Buchbinder","year":"1994","journal-title":"J Infect"},{"key":"10.1053\/jhep.2002.36380-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/oxfordjournals.aje.a116023","article-title":"Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland","volume":"134","author":"Donahue","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1053\/jhep.2002.36380-BIB19|cit19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(00)02681-7","article-title":"Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission","volume":"356","author":"Gibb","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB20|cit20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/339013","article-title":"Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs","volume":"185","author":"Resti","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB21|cit21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/infdis\/174.4.690","article-title":"Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users","volume":"174","author":"Thomas","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V84.4.1020.1020","article-title":"Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease","volume":"84","author":"Eyster","year":"1994","journal-title":"Blood"},{"key":"10.1053\/jhep.2002.36380-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB24|cit24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.510290311","article-title":"Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection","volume":"29","author":"Villano","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.36380-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community acquired hepatitis C in the United States","volume":"327","author":"Alter","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/jhep.2002.36380-BIB26|cit26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/jhep.2002.36380-BIB27|cit27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1086\/315314","article-title":"Determinants of the quantity of hepatitis C virus RNA","volume":"181","author":"Thomas","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB28|cit28","first-page":"602","article-title":"Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study","volume":"6","author":"Eyster","year":"1993","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/jhep.2002.36380-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/314720","article-title":"Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection","volume":"179","author":"Lesens","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB30|cit30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0168-8278(98)80341-3","article-title":"Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users","volume":"28","author":"Pol","year":"1998","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.36380-BIB31|cit31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/321909","article-title":"Influence of human immunodeficiency virus infection on the course of hepatitis c virus infection: a meta-analysis","volume":"33","author":"Graham","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/319273","article-title":"Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis c virus infection","volume":"183","author":"Ragni","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","article-title":"Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis","volume":"26","author":"Soto","year":"1997","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.36380-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.36380-BIB35|cit35","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1365-2141.1996.02343.x","article-title":"The natural history of chronic hepatitis C in haemophiliacs","volume":"94","author":"Makris","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1053\/jhep.2002.36380-BIB36|cit36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2141.1994.tb08312.x","article-title":"The progression of HCV-associated liver disease in a cohort of hemophiliac patients","volume":"87","author":"Telfer","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/jhep.2002.36380-BIB37|cit37","first-page":"2563","article-title":"Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV","volume":"91","author":"Rockstroh","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/jhep.2002.36380-BIB38|cit38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/jhep.2001.26517","article-title":"Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy","volume":"34","author":"Benhamou","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.36380-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/319747","article-title":"Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine\/Infectious Diseases, in 1995 and 1997","volume":"32","author":"Cacoub","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1053\/jhep.2002.33151","article-title":"Severity and correlates of liver disease in hepatitis C virus-infected injection drug users","volume":"35","author":"Rai","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.36380-BIB41|cit41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/jhep.2002.36380-BIB42|cit42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00002030-199804000-00006","article-title":"Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?","volume":"12","author":"Piroth","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/jhep.2002.36380-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study","volume":"356","author":"Greub","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB44|cit44","first-page":"1","article-title":"1999 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS\/IDSA Prevention of Opportunistic Infections Working Group. U.S. Public Health Services\/Infectious Diseases Society of America","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10.1053\/jhep.2002.36380-BIB45|cit45","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1097\/00002030-200012220-00011","article-title":"Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection","volume":"14","author":"den Brinker","year":"2000","journal-title":"AIDS"},{"key":"10.1053\/jhep.2002.36380-BIB46|cit46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.288.2.199","article-title":"Hepatitis C and HIV progression","volume":"288","author":"Sulkowski","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/jhep.2002.36380-BIB47|cit47","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10.1053\/jhep.2002.36380-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/00002030-199510000-00003","article-title":"High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV","volume":"9","author":"Cribier","year":"1995","journal-title":"AIDS"},{"key":"10.1053\/jhep.2002.36380-BIB49|cit49","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00042560-200104010-00008","article-title":"Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus","volume":"26","author":"Bonacini","year":"2001","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/jhep.2002.36380-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00002030-199012000-00016","article-title":"Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users","volume":"4","author":"Chamot","year":"1990","journal-title":"AIDS"},{"key":"10.1053\/jhep.2002.36380-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1097\/00002030-199817000-00010","article-title":"Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?","volume":"12","author":"John","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/jhep.2002.36380-BIB52|cit52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/infdis\/170.2.433","article-title":"Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay","volume":"170","author":"Marcellin","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB53|cit53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.1925601","article-title":"Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection","volume":"254","author":"Bukrinsky","year":"1991","journal-title":"Science"},{"key":"10.1053\/jhep.2002.36380-BIB54|cit54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nature"},{"key":"10.1053\/jhep.2002.36380-BIB55|cit55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/315283","article-title":"Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes\/macrophages and lymphocytes","volume":"181","author":"Laskus","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB56|cit56","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1182\/blood.V91.10.3841","article-title":"In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: Influence of viral load, viral genotype, and cell phenotype","volume":"91","author":"Lerat","year":"1998","journal-title":"Blood"},{"key":"10.1053\/jhep.2002.36380-BIB57|cit57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hep.510230202","article-title":"Hepatitis C virus: detection of intracellular virus particles by electron microscopy","volume":"23","author":"Shimizu","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.36380-BIB58|cit58","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/JCM.31.10.2679-2682.1993","article-title":"Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections","volume":"31","author":"Sherman","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1053\/jhep.2002.36380-BIB59|cit59","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/JVI.75.7.3259-3267.2001","article-title":"Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies","volume":"75","author":"Mao","year":"2001","journal-title":"J Virol"},{"key":"10.1053\/jhep.2002.36380-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin","volume":"331","author":"Bjoro","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/jhep.2002.36380-BIB61|cit61","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB62|cit62","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/JVI.76.6.2817-2826.2002","article-title":"Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses","volume":"76","author":"Lauer","year":"2002","journal-title":"J Virol"},{"key":"10.1053\/jhep.2002.36380-BIB63|cit63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00042560-199602010-00008","article-title":"Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV)","volume":"11","author":"Poles","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/jhep.2002.36380-BIB64|cit64","first-page":"1","article-title":"The hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination","volume":"40","author":"Centers for Disease Control and Prevention","year":"1991","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10.1053\/jhep.2002.36380-BIB65|cit65","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y","article-title":"Serological pattern \u201canti-HBc alone\u201d: report on a workshop","volume":"62","author":"Grob","year":"2000","journal-title":"J Med Virol"},{"key":"10.1053\/jhep.2002.36380-BIB66|cit66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01584356","article-title":"Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study","volume":"17","author":"Hofer","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB67|cit67","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/513918","article-title":"Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine","volume":"26","author":"Silva","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB68|cit68","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/hep.1840080411","article-title":"Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs","volume":"8","author":"Lok","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.36380-BIB69|cit69","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/infdis\/165.4.723","article-title":"Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus","volume":"165","author":"Boyer","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB70|cit70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/clinids\/23.3.585","article-title":"Interferon \u03b1 for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus","volume":"23","author":"Soriano","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB71|cit71","first-page":"400","article-title":"Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy","volume":"11","author":"Soriano","year":"1997","journal-title":"AIDS"},{"key":"10.1053\/jhep.2002.36380-BIB72|cit72","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/gut.47.5.694","article-title":"Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report","volume":"47","author":"Zylberberg","year":"2000","journal-title":"Gut"},{"key":"10.1053\/jhep.2002.36380-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/00002030-200109280-00006","article-title":"Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin","volume":"15","author":"Nasti","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/jhep.2002.36380-BIB74|cit74","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00002030-200111090-00010","article-title":"Long-term efficacy of combination therapy with interferon-alpha2b and ribavirin for severe chronic hepatitis C in HIV-infected patients","volume":"15","author":"Landau","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/jhep.2002.36380-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1053\/jhep.2001.29130","article-title":"Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders","volume":"34","author":"Sauleda","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/jhep.2002.36380-BIB76|cit76","unstructured":"Kostman JR Rodriguez-Torres M Prokupek D Brau N Bonacini M Hassanein T Smith J Results of a multicenter, randomized, double-blind, controlled trial of interferon alfa-2b\/ribavirin combination therapy in HCV\/HIV coinfected persons[Abstract]"},{"key":"10.1053\/jhep.2002.36380-BIB77|cit77","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(98)07236-5","article-title":"Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha","volume":"351","author":"Hepatocellular Carcinoma Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(95)91739-X","article-title":"Randomised trial of effects of interferon-\u03b1 on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis","volume":"346","author":"Nishiguchi","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB80|cit80","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"J Hepatol"},{"key":"10.1053\/jhep.2002.36380-BIB81|cit81","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-112-11-805","article-title":"Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial","volume":"112","author":"Lane","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1053\/jhep.2002.36380-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/jhep.2002.36380-BIB83|cit83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1086\/520178","article-title":"Human immunodeficiency virus infection, anemia, and survival","volume":"29","author":"Moore","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jhep.2002.36380-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.2435003","article-title":"Ribavirin antagonizes the effect of azidothymidine on HIV replication","volume":"235","author":"Vogt","year":"1987","journal-title":"Science"},{"key":"10.1053\/jhep.2002.36380-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/AAC.41.6.1231","article-title":"Effects of drugs on 2\u2032,3\u2032-dideoxy-2\u2032,3\u2032-didehydrothymidine phosphorylation in vitro","volume":"41","author":"Hoggard","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/jhep.2002.36380-BIB86|cit86","doi-asserted-by":"crossref","first-page":"21509","DOI":"10.1016\/S0021-9258(18)54668-8","article-title":"Mechanism of the potentiating effect of ribavirin on the activity of 2\u2032,3\u2032-dideoxyinosine against human immunodeficiency virus","volume":"266","author":"Balzarini","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1053\/jhep.2002.36380-BIB87|cit87","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0140-6736(00)03618-7","article-title":"Increased mitochondrial toxicity with ribavirin in HIV\/HCV coinfection","volume":"357","author":"Lafeuillade","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/jhep.2002.36380-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1097\/00002030-200008180-00025","article-title":"Lack of interference between ribavirin and nucleosidic analogues in HIV\/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy","volume":"14","author":"Landau","year":"2000","journal-title":"AIDS"},{"key":"10.1053\/jhep.2002.36380-BIB89|cit89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00007890-200107270-00001","article-title":"Solid organ transplantation in patients with HIV infection","volume":"72","author":"Gow","year":"2001","journal-title":"Transplantation"},{"key":"10.1053\/jhep.2002.36380-BIB90|cit90","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","article-title":"Correlates of hepatitis C virus infections among injection drug users in Baltimore","volume":"74","author":"Thomas","year":"1995","journal-title":"Medicine"},{"key":"10.1053\/jhep.2002.36380-BIB91|cit91","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/JCM.38.2.575-577.2000","article-title":"Screening for hepatitis C virus in human immunodeficiency virus-infected individuals","volume":"38","author":"Thio","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1053\/jhep.2002.36380-BIB92|cit92","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(98)80173-6","article-title":"Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients","volume":"29","author":"Pol","year":"1998","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.36380","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjhep.2002.36380","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200211002-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:46:46Z","timestamp":1738943206000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200211002-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":92,"URL":"https:\/\/doi.org\/10.1053\/jhep.2002.36380","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}